OTCMKTS:ITHUF

iAnthus Capital Competitors

$0.23
-0.01 (-4.19 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.21
Now: $0.23
$0.24
50-Day Range
$0.25
MA: $0.30
$0.39
52-Week Range
$0.05
Now: $0.23
$0.52
Volume494,754 shs
Average Volume1.30 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

iAnthus Capital (OTCMKTS:ITHUF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying ITHUF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to iAnthus Capital, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

iAnthus Capital (OTCMKTS:ITHUF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Earnings & Valuation

This table compares iAnthus Capital and Abacus Health Products' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iAnthus CapitalN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for iAnthus Capital and Abacus Health Products, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
iAnthus Capital0000N/A
Abacus Health Products0000N/A

Profitability

This table compares iAnthus Capital and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
iAnthus CapitalN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

iAnthus Capital (OTCMKTS:ITHUF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Earnings & Valuation

This table compares iAnthus Capital and Acreage's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iAnthus CapitalN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for iAnthus Capital and Acreage, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
iAnthus Capital0000N/A
Acreage01202.67

Acreage has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than iAnthus Capital.

Profitability

This table compares iAnthus Capital and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
iAnthus CapitalN/AN/AN/A
AcreageN/AN/AN/A

Summary

Acreage beats iAnthus Capital on 2 of the 2 factors compared between the two stocks.

iAnthus Capital (OTCMKTS:ITHUF) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Earnings & Valuation

This table compares iAnthus Capital and Applied Biosciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iAnthus CapitalN/AN/AN/AN/AN/A
Applied BiosciencesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for iAnthus Capital and Applied Biosciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
iAnthus Capital0000N/A
Applied Biosciences0000N/A

Profitability

This table compares iAnthus Capital and Applied Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
iAnthus CapitalN/AN/AN/A
Applied BiosciencesN/AN/AN/A

iAnthus Capital (OTCMKTS:ITHUF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Earnings & Valuation

This table compares iAnthus Capital and Ayr Strategies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iAnthus CapitalN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for iAnthus Capital and Ayr Strategies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
iAnthus Capital0000N/A
Ayr Strategies01602.86

Ayr Strategies has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts clearly believe Ayr Strategies is more favorable than iAnthus Capital.

Profitability

This table compares iAnthus Capital and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
iAnthus CapitalN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Summary

Ayr Strategies beats iAnthus Capital on 2 of the 2 factors compared between the two stocks.

iAnthus Capital (OTCMKTS:ITHUF) and Can B (NASDAQ:CANB) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Earnings & Valuation

This table compares iAnthus Capital and Can B's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iAnthus CapitalN/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for iAnthus Capital and Can B, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
iAnthus Capital0000N/A
Can B0000N/A

Profitability

This table compares iAnthus Capital and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
iAnthus CapitalN/AN/AN/A
Can BN/AN/AN/A

iAnthus Capital (OTCMKTS:ITHUF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Profitability

This table compares iAnthus Capital and Cansortium's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
iAnthus CapitalN/AN/AN/A
CansortiumN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for iAnthus Capital and Cansortium, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
iAnthus Capital0000N/A
Cansortium00103.00

Cansortium has a consensus price target of $1.20, indicating a potential upside of 43.13%. Given Cansortium's higher possible upside, analysts clearly believe Cansortium is more favorable than iAnthus Capital.

Earnings & Valuation

This table compares iAnthus Capital and Cansortium's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iAnthus CapitalN/AN/AN/AN/AN/A
CansortiumN/AN/AN/AN/AN/A

Summary

Cansortium beats iAnthus Capital on 2 of the 2 factors compared between the two stocks.


iAnthus Capital Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.06-316.7%$0.00N/A0.00Gap Up
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.56-1.0%$0.00N/A0.00Gap Up
Cansortium logo
CNTMF
Cansortium
1.1$0.84-1.2%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.30-4.8%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10-4.6%$0.00N/A0.00Gap Up
CPHRF
Cipher Pharmaceuticals
1.2$1.08-0.5%$0.00N/A0.00
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22-8.6%$0.00N/A0.00Gap Down
Cosmos logo
COSM
Cosmos
0.5$5.70-1.8%$0.00N/A0.00Gap Up
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.48-2.0%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.42-1.9%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-15.0%$0.00N/A0.00Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-3.4%$0.00N/A0.00Gap Down
EVIO
EVIO
0.6$0.00-0.0%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28-1.7%$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-0.0%$0.00N/A0.00Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-3.8%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.53-1.5%$0.00N/A0.00Gap Up
GTEC logo
GGTTF
GTEC
0.6$0.61-1.6%$0.00N/A0.00News Coverage
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.92-4.8%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-8.9%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6$5.30-1.8%$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68-0.0%$0.00N/A0.00
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.34-2.9%$0.00N/A0.00
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-17.0%$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.05-44.4%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.43-4.7%$0.00N/A0.00
KHTRF
Knight Therapeutics
1.2$4.20-0.5%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Gap Up
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-0.0%$0.00N/A0.00
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.40-5.0%$0.00N/A0.00
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.35-5.7%$0.00N/A0.00Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$34.83-1.4%$0.00N/A0.00
MJardin Group logo
MJARF
MJardin Group
1.1$0.08-12.8%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.03-18.1%$0.00N/A0.00News Coverage
Gap Up
PHCEF
Pharmacielo
0.7$1.44-1.4%$0.00N/A0.00
Plus Products logo
PLPRF
Plus Products
1.1$0.55-3.3%$0.00N/A0.00
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-4.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.70-0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-4.8%$0.00N/A0.00Gap Up
SANP
Santo Mining
0.5$0.01-0.0%$0.00N/A0.00Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.18-1.6%$0.00N/A0.00
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-7.8%$0.00N/A0.00Gap Up
TerrAscend logo
TRSSF
TerrAscend
1.7$9.80-3.2%$0.00N/A0.00
The Flowr logo
FLWPF
The Flowr
1.5$0.25-3.5%$0.00N/A0.00
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.31-3.2%$0.00N/A0.00Analyst Downgrade
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.